---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Abridge

🌎 abridge.com

Abridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.

---

Abridge - Latest News and Updates

• Abridge has expanded its services enterprise-wide across Deaconess Health System, Hurley Medical Center, and Saint Francis Healthcare System to improve clinician satisfaction and reduce administrative burden.
• Lightspeed Venture Partners, which manages $30 billion in assets, has invested in Abridge among other companies.
• Abridge is engaging with leaders from Duke, UNC Health, and Johns Hopkins at HIMSS and will be present at AONL 2025, showcasing its nationwide service to diverse health systems.
• Daniel Walker has joined Abridge as Director, Enterprise Development in the United States, previously serving as Director, Sales at Suki.
• Abridge will showcase its AI for nursing conversations at the AONL Inspiring Leaders Conference 2025 from March 30 to April 2, featuring a Lightning Talk with Julia Chou, COO at Abridge, and Ryannon Frederick, CNO at Mayo Clinic.

• Abridge's AI scribe pilots at the University of Vermont Health Network and Corewell Health reduced provider pajama time by 60% and 48%, respectively.
• Abridge is actively hiring as announced by Pranav Mani, ML Science at Abridge AI, on March 23, 2025.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.